AI Article Synopsis
- Autoimmune primary ovarian insufficiency (POI) is a serious condition with limited treatment options, prompting a systematic review to evaluate existing therapies and their effectiveness.
- A total of 28 studies, including randomized controlled trials (RCTs) and case reports, were reviewed, revealing that corticosteroids could help some patients, and treating comorbid autoimmune disorders might restore menstrual cycles or allow for pregnancies.
- While assisted reproductive technologies like IVF and IVM showed some success in achieving pregnancies, further research is necessary to better understand and improve treatment strategies for autoimmune POI.
Article Abstract
Autoimmune primary ovarian insufficiency (POI) is a devastating disease with limited clinical guidance. The objective of this systematic review was to identify treatments for autoimmune POI and analyze their efficacy. A comprehensive search of CINAHL, Cochrane, Embase, PubMed, Scopus, and Web of Science was performed from inception to April 2022. English language publications that evaluated women with autoimmune POI after a documented intervention were included. Animal models of autoimmune POI were also included. Risk of bias was assessed with the SYRCLE's risk of bias tool for animal studies or the NIH Quality Assessment Tool for Case Series as appropriate. Twenty-eight studies were included in this review, with 11 RCTs, 15 case reports, and 2 case series. Seventeen studies were in humans, and 11 were in animal models. No completed RCTs, cohort studies, or case-control studies were identified in humans. In observational human studies, corticosteroids were effective in select patients. In many case reports, adequate treatment of comorbid autoimmune conditions resulted in return of menses, hormonal normalization, or spontaneous pregnancy. In terms of assisted reproductive technologies, there was case report evidence for both in vitro fertilization (IVF) and in vitro maturation (IVM) in women wishing to conceive with their own oocytes. Ovulation induction, IVF, and IVM resulted in a total of 15 pregnancies and 14 live births. In animal models, there was additional evidence for stem cell therapies and treatments used in traditional Chinese medicine, although this research may not be generalizable to humans. Furthermore, litter size was not evaluated in any of the animal studies. Additional research is needed to establish the efficacy of current treatments for autoimmune POI with a controlled experimental design and larger sample size. Additionally, there is a critical need to develop novel therapies for this condition, as understanding of its pathophysiology and available tools to modulate the immune response have progressed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s43032-023-01299-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study.
Front Endocrinol (Lausanne)
December 2024
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Background: Observational studies suggest the risk of primary ovarian insufficiency (POI) is increased in autoimmune disorders (AIDs), but it is unclear whether there is a causal relationship. Therefore, we aimed to investigate the bidirectional causality between 20 AIDs and POI using Mendelian randomization (MR) analysis.
Methods: A bidirectional two-sample MR investigation was designed by using publicly accessible summary-level data from genome-wide association studies (GWAS).
Design and synthesis of JNK1-targeted PROTACs and research on the activity.
Bioorg Chem
December 2024
Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China. Electronic address:
Kinase dysregulation is greatly associated with cell growth, proliferation, differentiation and apoptosis, which indicates their great potential as therapeutic targets for treatment of numerous progressive disorders, including inflammatory, metabolic and autoimmune disorders, organ fibrosis and cancer. The c‑Jun N‑Terminal Kinase (JNK), as a member of MAPK family, is proved to be a potential target for the treatment of pulmonary fibrosis, which is the most common progressive and fatal fibrotic lung disease. As a new strategy, small-molecule-mediated targeted protein degradation pathway has the advantages of catalytic properties, overcoming drug resistance and expanding target space, which can circumvent the limitations associated with kinase inhibitors.
View Article and Find Full Text PDFImmune system regulation of physiological and pathological aspects of the ovarian follicle pool throughout the female reproductive lifespan.
Hum Reprod
January 2025
Gynecology Research Unit, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Article Synopsis
- The immune system regulates ovarian function by managing the balance of follicle activation and atresia through various signaling molecules like growth factors and cytokines.
- Different immune cells, such as macrophages, have distinct roles in follicle growth, and recent research highlights the existence of two populations of macrophages in the ovaries.
- Immune-related conditions, like premature ovarian insufficiency (POI), can arise from autoimmune responses or viral infections, prompting the need for further studies on new immunotherapies and their impact on ovarian health.
Autoimmune Disease is Increased in Women with Primary Ovarian Insufficiency.
J Clin Endocrinol Metab
November 2024
Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112.
Article Synopsis
- - Researchers studied the link between autoimmune diseases and women with primary ovarian insufficiency (POI) using health records from Utah, finding that 25% of POI women had at least one autoimmune condition.
- - Women with POI showed significantly higher risks for several autoimmune diseases, with conditions like autoimmune hypothyroidism and vitiligo being particularly prevalent compared to the general population.
- - Interestingly, the study found no increased risk of autoimmune diseases in the family members of women with POI, suggesting environmental factors might play a role rather than genetic inheritance.
Primary Ovarian Insufficiency, Bone Health, and Other Outcomes in Adolescents.
Obstet Gynecol Clin North Am
December 2024
Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, NICHD Office of the Clinical Director, 10 CRC, Room 5-2583, 10 Center Drive, MSC 1109, Bethesda, MD 20892, USA.
Article Synopsis
- - Adolescents with primary ovarian insufficiency (POI) often experience stopped puberty or absent menstrual periods, highlighting the need for early assessment of any menstrual issues to prevent delays in diagnosis.
- - POI can result from genetic, autoimmune, or medical treatment causes, but many cases do not have a known cause, making timely hormone replacement therapy essential for proper puberty development and overall health.
- - The diagnosis of POI can be surprising and significantly impact a teenager's life, requiring a compassionate approach that includes educational support and input from various healthcare specialists.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!